XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Mar. 31, 2020 $ 225 $ 64,649 $ 81,870 $ 2,099 $ 148,843
Balance (in shares) at Mar. 31, 2020 22,544,285        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     7,058   7,058
Cash dividend on common stock     (3,344)   (3,344)
Exercise of stock options $ 1 33     $ 34
Exercise of stock options (in shares) 14,000       14,000
Stock repurchased $ (3) (1,444)     $ (1,447)
Stock repurchased (in shares) (295,900)        
Restricted stock grants (in shares) 90,763        
Restricted stock cancelled (in shares) (7,913)        
Stock-based compensation expense   301     301
Other comprehensive income (loss), net       429 429
Balance at Dec. 31, 2020 $ 223 63,539 85,584 2,528 151,874
Balance (in shares) at Dec. 31, 2020 22,345,235        
Balance at Sep. 30, 2020 $ 222 63,420 82,666 2,738 149,046
Balance (in shares) at Sep. 30, 2020 22,336,235        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     4,035   4,035
Cash dividend on common stock     (1,117)   (1,117)
Exercise of stock options $ 1 24     25
Exercise of stock options (in shares) 9,000        
Stock-based compensation expense   95     95
Other comprehensive income (loss), net       (210) (210)
Balance at Dec. 31, 2020 $ 223 63,539 85,584 2,528 151,874
Balance (in shares) at Dec. 31, 2020 22,345,235        
Balance at Mar. 31, 2021 $ 223 63,650 87,881 (160) 151,594
Balance (in shares) at Mar. 31, 2021 22,351,235        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     17,695   17,695
Cash dividend on common stock     (3,552)   (3,552)
Exercise of stock options   17 (1)   $ 16
Exercise of stock options (in shares) 6,000       6,000
Stock repurchased $ (2) (1,722)     $ (1,724)
Stock repurchased (in shares) (249,908)        
Restricted stock grants (in shares) 69,285        
Stock-based compensation expense   289     289
Other comprehensive income (loss), net       (1,177) (1,177)
Balance at Dec. 31, 2021 $ 221 62,234 102,023 (1,337) 163,141
Balance (in shares) at Dec. 31, 2021 22,176,612        
Balance at Sep. 30, 2021 $ 221 62,122 97,727 (310) 159,760
Balance (in shares) at Sep. 30, 2021 22,164,707        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     5,510   5,510
Cash dividend on common stock     (1,214)   (1,214)
Restricted stock grants (in shares) 11,905        
Stock-based compensation expense   112     112
Other comprehensive income (loss), net       (1,027) (1,027)
Balance at Dec. 31, 2021 $ 221 $ 62,234 $ 102,023 $ (1,337) $ 163,141
Balance (in shares) at Dec. 31, 2021 22,176,612